• 11/06/2018

    PAION announces successful completion of Russian remimazolam Phase III clinical trial by Partner R-Pharm

  • 10/08/2018

    PAION announces clinical development progress with remimazolam by its partner Hana Pharm in South Korea

  • 09/12/2018

    PAION announces attendance at four upcoming conferences

  • 08/08/2018

    PAION AG reports financial results for the first half-year of 2018

  • 07/24/2018

    PAION starts EU Phase III trial with remimazolam in general anesthesia

  • 06/21/2018

    PAION AG raises EUR 5.2 million in private placement

  • 05/22/2018

    PAION announces attendance at two upcoming conferences

  • 05/17/2018

    PAION announces clinical development progress with remimazolam by its partner R-Pharm in Russia

  • 04/05/2018

    PAION participates at three upcoming conferences

  • 03/22/2018

    PAION announces clinical development progress with remimazolam by its partner Hana Pharm in South Korea

  • 03/22/2018

    PAION AG reports on fiscal year and financial results 2017

  • 02/08/2018

    PAION to present at three upcoming conferences